The asthmatic patient and inhaler treatment devices profile in Turkey: Asthma inhaler treatment study

F. Yildiz, N. Dursunoglu, S. Duru (Kocaeli, Denizli, Ankara, Turkey)

Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Session: Treatment of asthma, bronchiectasis and cough: inhaler use
Session type: Thematic Poster Session
Number: 2179
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Yildiz, N. Dursunoglu, S. Duru (Kocaeli, Denizli, Ankara, Turkey). The asthmatic patient and inhaler treatment devices profile in Turkey: Asthma inhaler treatment study. Eur Respir J 2012; 40: Suppl. 56, 2179

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Breath activated inhaler usage and impact on rescue medication usage in patients with an asthma diagnosis: a prescribing claims study of 2823 patients using a CFC - pMDI and a breath-actuated device
Source: Eur Respir J 2001; 18: Suppl. 33, 71s
Year: 2001

Asthma patients‘ preferences for single inhaler therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 285s
Year: 2004

How does the Novolizer fit into the choice of inhaler?
Source: Annual Congress 2005 - Asthma management - important issues
Year: 2005

Evaluation of adherence of patients with asthma to treatment by single combination inhaler
Source: Eur Respir J 2006; 28: Suppl. 50, 499s
Year: 2006

Preference of the inhaler device and assessment of the technique among the asthmatic and COPD patients
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011

Broncho dilator response to salbutamol delivered by metered dose inhaler with spacer versus dry powder inhaler in acute asthma in children
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016

Equivalence of an innovative multidose salmeterol/fluticasone dry powder inhaler vs comparator in paediatric asthma
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013

Effect of switching from salmeterol/fluticasone dry powder inhaler to formoterol/fluticasone pressurized metered-dose inhaler in elderly asthma patients
Source: International Congress 2016 – Asthma management
Year: 2016


The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Year: 2016


Comparing objective inhaler use among COPD and Asthma populations
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Year: 2018



Description of the UK’s asthma and COPD inhaler use
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018

Preferences for current inhaler devices in patients with asthma
Source: International Congress 2018 – Asthma and drugs
Year: 2018


The budesonide/formoterol inhaler as maintenance and reliever therapy in Maori asthmatics
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013

Clinical evaluation of fluticasone/formoterol twice daily delivered via a single dose dry powder inhaler in patients with persistent asthma
Source: International Congress 2016 – Asthma management
Year: 2016


Assessment of inhalation technique and satisfaction with inhalers in asthmatic patients
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020


Add-on effects of long-acting beta2-agonists salmeterol inhaler vs tulobuterol patch in adult patients with mild-to-moderate asthma
Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs
Year: 2013


Identification of asthma level of control using administrative data of short-acting beta-agonist inhalers purchase
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016

Comparison of HFA salmeterol-fluticasone (SFC) combination when given through breath actuated inhaler (BAI) and pressurised meter dose inhaler (pMDI) in patients with moderate-to-severe asthma
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013


The effects of different inhaler devices on asthma control in patients with persistent asthma in Turkey
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012